THYROCARE vs RELIANCE
Head-to-head DCF comparison · THYROCARE TECH LTD vs Reliance Industries
Model Favors
THYROCARE shows a larger model margin of safety
Leads on 4 of 4model metrics · not investment advice
THYROCARE
THYROCARE TECH LTD
Hospitals
₹388
Fairly ValuedRELIANCE
Reliance Industries
Oil & Gas
₹1,353
Overvalued| Metric | THYROCARE | RELIANCE |
|---|---|---|
| Verdict | Fairly Valued | Overvalued |
| YieldIQ Score | 70/100 | 28/100 |
| Fair Value | ₹423 | ₹879 |
| Current Price | ₹388 | ₹1,353 |
| Margin of Safety | +8.9% | -35.0% |
| Moat | Wide | Moderate |
| Piotroski F-Score | 8/9 | 5/9 |
| ROE | — | — |
| Debt / Equity | 0.05 | 0.36 |
| EV / EBITDA | 25.5× | 12.8× |
| Market Cap | ₹6,178 Cr | ₹18.31 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.